Season 10 · Episode 33
S10 Ep33: Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
OncLive® On Air · OncLive® On Air
May 30, 202410m 3s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.